| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |